Clostridium difficile-associated disease in Oregon: Increasing incidence and hospital-level risk factors

Infection Control and Hospital Epidemiology

Volumn 28, Issue 2, 2007, Pages 116-122

  Chandler, Rebecca E ^a,b   Hedberg, Katrina ^a   Cieslak, Paul R ^a,c  

^a Department of Human Services ^*  (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Acute and Communicable Disease Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; MOXIFLOXACIN;

ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DRUG USE; HOSPITAL BED; HOSPITAL DISCHARGE; HOSPITAL LABORATORY; HOSPITAL PERSONNEL; HOSPITAL POLICY; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION CONTROL PRACTITIONER; INFECTION RATE; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MEDICAL RECORD; PHARMACIST; QUESTIONNAIRE; UNITED STATES;

CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INFECTION CONTROL; OREGON; RISK FACTORS;

EID: 33847762359     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/511795     Document Type: Article

References (36)

1. Riley TV. The epidemiology of Clostridium difficile-associated diarrhoea. Rev Med Microbiol 1994; 5:117-122.
2. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330:257-262.
3. Fekety R, Shah AB. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993; 269:71-75.
4. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998; 26:1027-1036.
5. Spencer RC. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother 1998; 41 (Suppl):21-27.
6. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204-210.
7. Samore MH. Epidemiology of nosocomial Clostridium difficile diarrhoea. J Hosp Infect 1999; 43(Suppl):S183-S190.
8. Oison MM, Shanholzer CJ, Lee JTJ, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994; 15:371-381.
9. Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. Risk factors for Clostridium difficile toxin-associated diarrhoea. Infect Control Hosp Epidemiol 1990; 11:283-290.
10. Samore MH, Bettin KM, DeGirolami PC, Clabots CR, Gerding DN, Karchmer AW. Wide diversity of Clostridium difficile types at a tertiary referral hospital. J Infect Dis 1994; 170:615-621.
11. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996; 100:32-40.
12. Struelens MJ, Maas A, Nonhoff C, et al. Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. Am J Med 1991; 91:1385-1445.
13. Karlstrom O, Fryland B, Tullus K, Burman G. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. Clin Infect Dis 1998; 26:141-145.
14. Alfa MJ, Du T, Beda G. Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol 1998; 36:2076-2080.
15. Thomas C, Stevenson M, Williamson DJ, Riley RV. Clostridium difficile-associated diarrhea: epidemiological data from western Australia associated with a modified antibiotic policy. Clin Infect Dis 2002; 35:1457-1462.
16. McDonald LC, Banerjee SN, Jernigan DB. Increasing incidence of Clostridium difficile-associated disease in US acute care hospitals. In: Program and abstracts of the Society for Hospital Epidemiology of America Annual Meeting, April 17, 2004-April 20, 2004. Philadelphia, PA. Abstract 67.
17. Pépin J, Valiquette L, Alary M-E, Villemure P, Pelletier A, Forget K, Pépin K, Chouinard D. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171:466-472.
18. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162:678-684.
19. Kyne L, Sougioultzis C, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002; 23:653-659.
20. Pierce PF Jr, Wilson R, Silva J Jr, et al. Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis 1982; 145:269-274.
21. Bliss DZ, Johnson S, Savik K, Clabots CR, Willard K, Gerding DN. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients who received tube feeding. Ann Intern Med 1998; 129:1012-1019.
22. Anand A, Glatt AE. Clostridium difficile infection associated with anti-neoplastic chemotherapy: a review. Clin Infect Dis 1993; 17:109-113.
23. Cunningham R, Dale B, Undy B, Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003; 54:243-245.
24. Portland State Population Research Center. Available at: http://www.upa .pdx.edu/CPRC/publications/annualorpopulation. Accessed August 30, 2004.
25. Kaiser State Health Facts Database. Available at: http://www. statehealthfacts .org/cgi-bin/healthfacts.cgi. Accessed August 30, 2004.
26. Hirschhorn LR, Trnka Y, Onderdonk A, Lee M-LT, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994; 169:127-133.
27. Frost F, Hurley JS, Petersen HV, Casciano RN. Estimated incidence of Clostridium difficile infection. Emerg Infect Dis 1999; 5:302-303.
28. Kralovic SM, Danko LH, Simbartl LA, Roselle GA. Clostridium difficile infection in VA medical centers nationwide. In: Program and abstracts of the Society for Hospital Epidemiology of America Annual Meeting; April 9, 2005-April 12, 2005. Los Angeles, CA. Abstract 284.
29. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United Sates, 1987-2001. J Infect Dis 2004; 189:1585-1589.
30. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16:459-477.
31. Barbut F, Delmee M, Brazier JS, et al. A European survey of diagnostic methods and testing protocols for Clostridium difficile. ESCMID Study Group on Clostridium difficile. Clin Microbiol Infect 2003; 9:989-996.
32. Clabots CR, Gerding SJ, Olson MM, Peterson LR, Gerding DN. Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure. J Clin Microbiol 1989; 27:2386-2387.
33. McCusker ME, Harris AD, Perencevich E, Roghmann M. Fluoroquinolone use and Clostridium difficile-associated diarrhea. Emerg Infect Dis 2003; 9:730-733.
34. Gaynes R, Rimland D, Killum E, Lowery K, Johnson II TM, Kilgore G, Tenover FC. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 2004; 38:640-645.
35. Khan R, Cheesbrough J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhea over a five-year period in a district general hospital. J Hosp Infect 2003; 54:104-108.
36. O'Connor KA, Kingston M, O'Donovan M, Cryan B, Twomey C, O'Mahony D. Antibiotic prescribing policy and Clostridium difficile diarrhea. QJM 2004; 97:423-429.